# FDA Inspection 1201259 - AlloSource - March 30, 2023

Source: https://www.keypedia.com/records/fda_inspections/allosource/9feeb28f-e5dc-4eb3-8401-23c3664c6f22
Source feed: FDA_Inspections

> FDA Inspection 1201259 for AlloSource on March 30, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1201259
- Company Name: AlloSource
- Inspection Date: 2023-03-30
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1201259 - 2023-03-30](https://www.keypedia.com/records/fda_inspections/allosource/610223db-9c3e-4298-9d27-5a605327bdd0)
- [FDA Inspection 1201259 - 2023-03-30](https://www.keypedia.com/records/fda_inspections/allosource/03bdc794-27e4-4c7d-b856-31243b4965a4)
- [FDA Inspection 1175639 - 2022-07-27](https://www.keypedia.com/records/fda_inspections/allosource/9b04fc30-dcbb-4079-8720-45f37845ea74)
- [FDA Inspection 1175639 - 2022-07-27](https://www.keypedia.com/records/fda_inspections/allosource/1186423f-c340-431d-974b-f8489af38c45)
- [FDA Inspection 1074854 - 2018-12-18](https://www.keypedia.com/records/fda_inspections/allosource/bb193ac1-e1f8-4240-b903-129e24667479)

Company: https://www.keypedia.com/companies/allosource/561511d2-2b9d-4a29-9565-deccb49a8455

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d